Accounting for white matter uptake improves between tracer agreement in amyloid PET.

IF 4.4 Q1 CLINICAL NEUROLOGY
Yinghua Chen, Hillary Protas, Ji Luo, Shan Li, Javad Sohankar, Chen-Ray Pan, Valentina Ghisays, Wendy Lee, Teresa Wu, Ding-Geng Chen, Eric M Reiman, Kewei Chen, Yi Su
{"title":"Accounting for white matter uptake improves between tracer agreement in amyloid PET.","authors":"Yinghua Chen, Hillary Protas, Ji Luo, Shan Li, Javad Sohankar, Chen-Ray Pan, Valentina Ghisays, Wendy Lee, Teresa Wu, Ding-Geng Chen, Eric M Reiman, Kewei Chen, Yi Su","doi":"10.1002/dad2.70165","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Amyloid positron emission tomography (PET) allows in vivo measurement of amyloid plaque deposition; however, different tracers lead to different results. We test the hypothesis that the variability in amyloid measurements is related to white matter retention, and accounting for this variability can improve agreements.</p><p><strong>Methods: </strong>Data from the Centiloid project was downloaded and processed for four F18 tracer-to-Pittsburgh Compound B (PiB) pairs to obtain mean cortical standardized uptake value ratio (MCSUVR). Three approaches were examined to account for white matter contribution to the MCSUVR. Pearson's correlation was used to assess the between tracer agreements. Steiger's test was used to determine the significance of improvement.</p><p><strong>Results: </strong>Accounting for white matter signal improves the agreement. The regional spread function partial volume correction (RSF PVC) method was most consistent in achieving statistically significant improvements (<i>p</i> < 0.05) for all four tracer pairs.</p><p><strong>Discussion: </strong>Between-tracer agreement of amyloid measure can be improved by accounting for white matter signal. Further investigation is ongoing for additional improvement.</p><p><strong>Highlights: </strong>Analyzing head-to-head data for all four common F18-labeled tracers against Pittsburgh Compound B (PiB).Evaluating three different techniques to correct for white matter signal.Steiger's test to determine the significance of improvements.White matter uptake contributes to the between-tracer measurement difference.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 3","pages":"e70165"},"PeriodicalIF":4.4000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375990/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70165","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Amyloid positron emission tomography (PET) allows in vivo measurement of amyloid plaque deposition; however, different tracers lead to different results. We test the hypothesis that the variability in amyloid measurements is related to white matter retention, and accounting for this variability can improve agreements.

Methods: Data from the Centiloid project was downloaded and processed for four F18 tracer-to-Pittsburgh Compound B (PiB) pairs to obtain mean cortical standardized uptake value ratio (MCSUVR). Three approaches were examined to account for white matter contribution to the MCSUVR. Pearson's correlation was used to assess the between tracer agreements. Steiger's test was used to determine the significance of improvement.

Results: Accounting for white matter signal improves the agreement. The regional spread function partial volume correction (RSF PVC) method was most consistent in achieving statistically significant improvements (p < 0.05) for all four tracer pairs.

Discussion: Between-tracer agreement of amyloid measure can be improved by accounting for white matter signal. Further investigation is ongoing for additional improvement.

Highlights: Analyzing head-to-head data for all four common F18-labeled tracers against Pittsburgh Compound B (PiB).Evaluating three different techniques to correct for white matter signal.Steiger's test to determine the significance of improvements.White matter uptake contributes to the between-tracer measurement difference.

Abstract Image

Abstract Image

淀粉样PET示踪剂之间的白质摄取改善。
淀粉样正电子发射断层扫描(PET)允许体内测量淀粉样斑块沉积;然而,不同的示踪剂导致不同的结果。我们测试了淀粉样蛋白测量的可变性与白质保留有关的假设,并解释了这种可变性可以改善协议。方法:下载Centiloid项目数据,对4对F18示踪剂-匹兹堡化合物B (PiB)进行处理,获得平均皮质标准化摄取值比(MCSUVR)。研究了三种方法来解释白质对MCSUVR的贡献。使用Pearson相关性来评估示踪剂之间的一致性。使用Steiger试验来确定改善的意义。结果:考虑白质信号可提高一致性。区域扩散函数部分体积校正(RSF PVC)方法在实现统计学显著改善方面是最一致的(p)。讨论:考虑白质信号可以提高淀粉样蛋白测量的示踪剂间一致性。正在进行进一步调查以进一步改进。重点:分析所有四种常见的f18标记示踪剂对匹兹堡化合物B (PiB)的头对头数据。评估三种不同的技术来纠正白质信号。用斯泰格氏试验来确定改进的重要性。白质摄取有助于示踪剂之间的测量差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
7.50%
发文量
101
审稿时长
8 weeks
期刊介绍: Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信